Cargando…
Ongoing data from the breast cancer prevention trials: opportunity for breast cancer risk reduction
Selective estrogen receptor modulators (SERMs) reduce the risk of recurrence of invasive breast cancer and the incidence of first breast cancers in women who are at increased risk. Multiple, randomized clinical trials have shown both the efficacy and safety of SERMs in reducing the risk of breast ca...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376369/ https://www.ncbi.nlm.nih.gov/pubmed/25888872 http://dx.doi.org/10.1186/s12916-015-0300-0 |